Samuel Henderson
Chief Tech/Sci/R&D Officer at Cerecin, Inc.
Profile
Samuel Henderson is currently the Chief Scientific Officer at Cerecin, Inc. Previously, he worked as a Principal at The University of Colorado and as a Lead Scientist at Genoplex, Inc. He completed his undergraduate degree at the University of Washington and obtained his doctorate from the University of Chicago.
Samuel Henderson active positions
| Companies | Position | Start |
|---|---|---|
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Chief Tech/Sci/R&D Officer | - |
Former positions of Samuel Henderson
| Companies | Position | End |
|---|---|---|
| Genoplex, Inc. | Chief Tech/Sci/R&D Officer | - |
| The University of Colorado | Corporate Officer/Principal | - |
Training of Samuel Henderson
| University of Washington | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
| Genoplex, Inc. |
- Stock Market
- Insiders
- Samuel Henderson
